Vascular-targeted nanotherapy for obesity: Unexpected passive targeting mechanism to obese fat for the enhancement of active drug delivery
- 1 October 2012
- journal article
- Published by Elsevier BV in Journal of Controlled Release
- Vol. 163 (2), 101-110
- https://doi.org/10.1016/j.jconrel.2012.09.002
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 15 references indexed in Scilit:
- A Peptidomimetic Targeting White Fat Causes Weight Loss and Improved Insulin Resistance in Obese MonkeysScience Translational Medicine, 2011
- Vascular ligand-receptor mapping by direct combinatorial selection in cancer patientsProceedings of the National Academy of Sciences of the United States of America, 2011
- Targeting neuropilin-1 in human leukemia and lymphomaBlood, 2011
- Effect of PEG chain length and hydrophilic weight fraction on polymersomes prepared from branched (PEG)3‐PLA co‐polymersPolymers for Advanced Technologies, 2010
- Ligand-based targeted delivery of a peptide modified nanocarrier to endothelial cells in adipose tissueJournal of Controlled Release, 2010
- A multifunctional envelope type nano device (MEND) for gene delivery to tumours based on the EPR effect: A strategy for overcoming the PEG dilemmaAdvanced Drug Delivery Reviews, 2010
- Isolation and culture of microvascular endothelial cells from murine inguinal and epididymal adipose tissuesJournal of Immunological Methods, 2010
- Peptide Designed to Elicit Apoptosis in Adipose Tissue Endothelium Reduces Food Intake and Body WeightDiabetes, 2010
- Adipogenesis in Obesity Requires Close Interplay Between Differentiating Adipocytes, Stromal Cells, and Blood VesselsDiabetes, 2007
- Angiogenesis Inhibitor, TNP-470, Prevents Diet-Induced and Genetic Obesity in MiceCirculation Research, 2004